Efficacy and safety of automated insulin delivery system in very young children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials

医学 糖尿病酮症酸中毒 临床终点 1型糖尿病 随机对照试验 胰岛素释放 胰岛素 糖尿病 儿科 临床试验 糖化血红蛋白 酮症酸中毒 内科学 2型糖尿病 血糖自我监测 连续血糖监测 重症监护医学 糖化血红素 研究设计 梅德林 低血糖 不利影响 风险评估 糖尿病管理 糖尿病治疗 年轻人 输送系统 注意事项 内分泌学
作者
Qiongyan Lin,Y Zhou,Mengyun Lei,Ping Ling,Ying Ni,Ziqing Lin,Daizhi Yang,Wen Xu,Hongrong Deng,Jinhua Yan
出处
期刊:Diabetic Medicine [Wiley]
卷期号:: e70354-e70354
标识
DOI:10.1111/dme.70354
摘要

Abstract Aim To evaluate the efficacy and safety of automated insulin delivery (AID) systems in very young children with type 1 diabetes (T1D). Methods PubMed, Embase, Scopus, and Web of Science were searched until 10 October 2025. Inclusion criteria were randomized controlled trials (RCTs); T1D populations under 7 years old; comparing AID systems with standard care (SC). Primary efficacy endpoint was the percentage of time‐in‐range of 70–180 mg/dL (TIR) derived from continuous glucose monitoring (CGM), secondary outcomes included glycated haemoglobin (HbA1c), other CGM metrics, and insulin dose. Safety endpoints included severe hypoglycaemia (SH) and diabetic ketoacidosis (DKA). Results Four RCTs involving 292 participants were included. The mean age was 4.70 years, with a mean T1D duration of 1.96 years. The study duration ranged from 8 to 16 weeks. Compared with SC, AID significantly improved TIR by mean difference (MD) +9.29% (95% confidence interval [CI]: 7.27–11.30, I 2 = 70%, p < 0.001) accompanied by a favourable effect on HbA1c by MD −4 mmol/mol (−0.39%) (95% CI [−6 to −2] (−0.57 to −0.21), I 2 = 82%, p < 0.001). A favourable decrease in time‐above‐range (TAR, >180 mg/dL; >250 mg/dL) and mean blood glucose were also observed in AID over SC (all p < 0.05). No significant differences were observed between AID and SC groups in time in hypoglycaemia, insulin dose, and risk of SH and DKA (all p > 0.05). Conclusion AID systems may outperform SC in improving short‐term glycaemic control (TIR, HbA1c, TAR) in very young children with T1D, without increasing time in hypoglycaemia, insulin dose, or risk of SH and DKA. These preliminary findings support the clinical potential of AID systems and highlight the need for longer term studies.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
阡陌完成签到,获得积分10
1秒前
苏苏苏发布了新的文献求助10
2秒前
大将军发布了新的文献求助10
3秒前
温暖秋蝶发布了新的文献求助10
4秒前
AdAstra完成签到,获得积分10
6秒前
熊风完成签到,获得积分10
6秒前
7秒前
张颖涛发布了新的文献求助10
7秒前
小马甲的应助被竟文采纳,获得10
8秒前
sunny完成签到 ,获得积分10
9秒前
9秒前
lu7完成签到 ,获得积分10
10秒前
星野的应助被予诺采纳,获得10
11秒前
回锅肉完成签到 ,获得积分10
13秒前
胖球球完成签到,获得积分10
13秒前
Hsy驳回了Lucas的应助
13秒前
好名发布了新的文献求助10
14秒前
ZY发布了新的文献求助10
15秒前
16秒前
19秒前
张颖涛完成签到,获得积分10
19秒前
领导范儿的应助被灭建国采纳,获得10
19秒前
20秒前
隐形曼青的应助被FUTURE采纳,获得30
21秒前
orixero的应助被Joy采纳,获得10
21秒前
Jingxue_ZX的应助被武宁采纳,获得10
24秒前
24秒前
我是谁的应助被朴实归尘采纳,获得50
25秒前
桐桐的应助被孟宇采纳,获得10
25秒前
柚子完成签到,获得积分10
25秒前
领导范儿的应助被大将军采纳,获得10
26秒前
哈哈哈哈发布了新的文献求助10
27秒前
28秒前
28秒前
29秒前
weiqiliang完成签到,获得积分10
29秒前
jason完成签到,获得积分0
29秒前
栖梧砚客完成签到,获得积分10
31秒前
32秒前
折瑾完成签到,获得积分10
34秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188371
求助须知:如何正确求助?哪些是违规求助? 9576179
关于积分的说明 21845965
捐赠科研通 7786421
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559601
邀请新用户注册赠送积分活动 2482276